BRIACELL THERAPEUTICS CORP. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BRIACELL THERAPEUTICS CORP. stock issued during period, shares, new issues for the quarter ending 2025-10-31 was 0.00 shares.
- BRIACELL THERAPEUTICS CORP. stock issued during period, shares, new issues for the quarter ending 2024-04-30 was 0.00 shares.
- BRIACELL THERAPEUTICS CORP. stock issued during period, shares, new issues for the quarter ending 2024-01-31 was 0.00 shares.
- BRIACELL THERAPEUTICS CORP. stock issued during period, shares, new issues for the quarter ending 2023-10-31 was 0.00 shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2025-10-31 | 0.00 shares 10-Q · filed 2025-12-11 | |
| 2024-04-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-06-14 | |
| 2024-01-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-03-18 | |
| 2023-10-31 | 0.00 shares 10-Q · filed 2023-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |